Novel strategies for targeted therapy in NETs: inhibition of Wnt signaling in neuroendocrine tumors and improving peptide receptor chemoradionuclide therapy (PRCRT) by a combination of 5-fluorouracil and epigenetic modifiers
Online Katalog der Universitätsbibliothek der LMU München (1/1)
Ablegen in:
Novel strategies for targeted therapy in NETs: inhibition of Wnt signaling in neuroendocrine tumors and improving peptide receptor chemoradionuclide therapy (PRCRT) by a combination of 5-fluorouracil and epigenetic modifiers
Novel strategies for targeted therapy in NETs: inhibition of Wnt signaling in neuroendocrine tumors and improving peptide receptor chemoradionuclide therapy (PRCRT) by a combination of 5-fluorouracil and epigenetic modifiers